Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07644832
An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII DeficiencyShanghai RAAS Blood Products Co., Ltd.RecruitingPhase 1
NCT07644832Recruiting
Phase 1
An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tol...Shanghai RAAS Blood Produ...
NCT07644260
Transition From Sevoflurane to Total Intravenous Anesthesia in Pediatric PatientsHospital de Clinicas José de San MartínNot Yet Recruiting
NCT07644260Not Yet Recruiting
—
Transition From Sevoflurane to Total Intravenous Anesthesia in Pediatric Patient...Hospital de Clinicas José...
NCT07645183
Advanced Technology for Myopia Control in Children and Young AdultsUniversity of FaisalabadCompletedNot Applicable
NCT07645183Completed
Not Applicable
Advanced Technology for Myopia Control in Children and Young AdultsUniversity of Faisalabad
NCT07645326
RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Georgetown UniversityNot Yet RecruitingPhase 2
NCT07645326Not Yet Recruiting
Phase 2
RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Georgetown University
NCT07646353
First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy AdultsGlaxoSmithKlineNot Yet RecruitingPhase 1
NCT07646353Not Yet Recruiting
Phase 1
First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in H...GlaxoSmithKline
NCT07646418
Combined Effects of LIRT-BFR Therapy in Post- Stroke PatientsRiphah International UniversityRecruitingNot Applicable
NCT07646418Recruiting
Not Applicable
Combined Effects of LIRT-BFR Therapy in Post- Stroke PatientsRiphah International Univ...
NCT07646548
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsRegeneron PharmaceuticalsNot Yet RecruitingPhase 1
NCT07646548Not Yet Recruiting
Phase 1
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Be...Regeneron Pharmaceuticals
NCT07644962
Research Project on the Interaction Between Immune Function and Infectious Diseases in Older Adults and the Development of Prevention and Control StrategiesHuashan HospitalNot Yet Recruiting
NCT07644962Not Yet Recruiting
—
Research Project on the Interaction Between Immune Function and Infectious Disea...Huashan Hospital
NCT07643792
Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Fracture SurgeryPeking University First HospitalNot Yet RecruitingPhase 4
NCT07643792Not Yet Recruiting
Phase 4
Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Fracture...Peking University First H...
NCT07645508
Comparison of Conventional, Patient-Specific, and Augmented Reality Navigation in Reverse Total Shoulder ArthroplastyKrankenhaus Barmherzige Schwestern LinzActive Not Recruiting
NCT07645508Active Not Recruiting
—
Comparison of Conventional, Patient-Specific, and Augmented Reality Navigation i...Krankenhaus Barmherzige S...
NCT07644585
A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and NeckIBA Proton Therapy, Inc.Not Yet RecruitingNot Applicable
NCT07644585Not Yet Recruiting
Not Applicable
A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Ca...IBA Proton Therapy, Inc.
NCT07645443
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early PsychosisCentral Institute of Mental Health, MannheimRecruitingNot Applicable
NCT07645443Recruiting
Not Applicable
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adu...Central Institute of Ment...
NCT07645469
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid LeukemiaFred Hutchinson Cancer CenterNot Yet RecruitingPhase 1
NCT07645469Not Yet Recruiting
Phase 1
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Di...Fred Hutchinson Cancer Ce...
NCT07645560
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic StrokeBeijing Tiantan HospitalNot Yet RecruitingPhase 2
NCT07645560Not Yet Recruiting
Phase 2
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After...Beijing Tiantan Hospital
NCT07645300
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD TrialMichael E. DeBakey VA Medical CenterNot Yet RecruitingPhase 2
NCT07645300Not Yet Recruiting
Phase 2
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD TrialMichael E. DeBakey VA Med...
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07645859
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuous Training in Chronic Non-Specific Low Back Pain PatientsDow University of Health SciencesRecruitingNot Applicable
NCT07645859Recruiting
Not Applicable
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuou...Dow University of Health...
NCT07644234
Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic StrokeSichuan Provincial People's HospitalNot Yet RecruitingPhase 4
NCT07644234Not Yet Recruiting
Phase 4
Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patie...Sichuan Provincial People...
NCT07645599
Microvasculature Ultrasound Super-resolution in Transplant Delayed Graft FunctionRoderick TanNot Yet Recruiting
NCT07645599Not Yet Recruiting
—
Microvasculature Ultrasound Super-resolution in Transplant Delayed Graft Functio...Roderick Tan
Result Breakdown
Not yet recruiting13 (65%)
Recruiting5 (25%)
Completed1 (5%)
Active, not recruiting1 (5%)
Not Specified5 (25%)
not_applicable5 (25%)
Phase 14 (20%)
Phase 24 (20%)
Phase 42 (10%)